Developing an Effective Therapeutic HPV Vaccine to Eradicate Large Tumors by Genetically Fusing Xcl1 and Incorporating IL-9 as Molecular Adjuvants
the fusion of Xcl1 and the use of IL-9 as a molecular adjuvant represent promising strategies for vaccine development.
Authors
- Xun‐Cheng Su (ORCID: https://orcid.org/0000-0003-3051-0047)
- Zhongyan Wu (ORCID: https://orcid.org/0000-0001-9018-9115)
- Zhen-Xing Sun
Institutions
- Nankai University (CN)
Publication Details
- Journal
- Vaccines
- Published
- 2025-01-09
- DOI
- https://doi.org/10.3390/vaccines13010049
- Primary Topic
- Immunotherapy and Immune Responses
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China